Almac

Almac’s ePRO solutions are used to support post-marketing pharmacovigilance programs, forming a vital part of any sponsor company’s overall risk management strategy. Almac’s ePRO solutions:

• Manage the capture of additional data from large patient populations about the long-term safety of new products in real-world settings
• Facilitate the reporting of adverse events and other safety concerns, ensuring that a product’s benefit-to-risk profile remains acceptable
• Support healthcare providers – and those who pay for healthcare – by collecting clinical evidence that new therapies provide better outcomes or greater value than existing products on the market

For more detailed information, visit our ePRO micro site at www.almacgroup.com/ePRO